Last reviewed · How we verify
NCT05506631: Balloon
Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening
NA trial testing Outpatient Foley balloon placement in Pregnancy Outcome in 140 participants. Completed in 30 October 2024.
30 May 2024
Quick facts
| Lead sponsor | Lehigh Valley Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 140 |
| Start date | 1 November 2021 |
| Primary completion | 30 May 2024 |
| Estimated completion | 30 October 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Outpatient Foley balloon placement
- Inpatient Foley Balloon placement
Conditions studied
- Pregnancy Outcome — all drugs for Pregnancy Outcome →
Sponsor
Lehigh Valley Hospital
Who can join
Adults 18 to 39, female only, with Pregnancy Outcome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to determine the impact of outpatient cervical ripening with transcervical balloon placement for induction of labor at term on the length and cost of inpatient hospitalization when compared to inpatient cervical ripening.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05506631
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pregnancy Outcome
Currently open trials in the same condition.
- NCT06705712 — Physical Activity, Fertility, and Spontaneous Abortion in Danish Couples Trying to Conceive · NA · recruiting
- NCT05870878 — Generation R Next - Optimaal Opgroeien · NA · recruiting
- NCT05733377 — Non-invasive Imaging Technique for the Study of Lordosis in Pregnant Women and Its Relationship to Birth Outcome · recruiting
- NCT03215368 — The Ma'Anshan Birth Cohort (MABC) · active not recruiting
- NCT04529889 — GDM and Its Consequences in Mothers and Offsprings · recruiting
Other Lehigh Valley Hospital trials
Trials by the same sponsor.
- NCT02982096 — Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05506631 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lehigh Valley Hospital
- Last refreshed: 31 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05506631.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing